Search - tctmd.com

Displaying 941 - 960 of 1002

Sort: Relevancy | Date

News Daily News

Studies Suggest 3-D CT Prior to TAVR Should Be ‘Gold Standard’

Yael L. Maxwell

March 07, 2012

News Daily News

Stem Cell Therapy Moderately Improves Cardiac Function After Acute MI

L.A. McKeown

March 07, 2012

News Daily News

Procedural Complications Not to Blame for Death After PCI

March 06, 2012

News Daily News

Percutaneous Valve Replacement Stakes Out the Tricuspid

March 06, 2012

News Daily News

Percutaneous AV Shunt May Do More Harm Than Good in Advanced COPD

March 06, 2012

News Daily News

La OTC Coronaria Dcha. Predice Mortalidad Tras PCI Principal Dcha

Leah Lawrence

March 06, 2012

News Daily News

Renal Denervation Bonus: Improving LV Function

March 05, 2012

News Daily News

El Valor Añadido de la Denervación Renal: Mejora la Función del VI

March 05, 2012

News Daily News

Mitral Repair Can Augment Heart Function in CABG Patients

Caitlin E. Cox

March 04, 2012

News Daily News

La Reparación Mitral Puede Aumentar la Función Cardíaca en Pacientes sometidos a CABG

Caitlin E. Cox

March 04, 2012

News Conference News Cell Therapy 2012

Novel Strategies Advance Cell Therapy for Cardiomyopathy

February 05, 2012

News Conference News Cell Therapy 2012

Expedited Cell Therapy After STEMI Shows Promise

January 29, 2012

News Daily News

EVEREST II Registry Looks at MitraClip in High-Risk Patients

Jason Kahn

January 04, 2012

News Daily News

Studies Show Valve-in-Valve TAVR Successful for Failed Surgical Bioprostheses

L.A. McKeown

December 29, 2011

News Daily News

Higher Intra-aortic Balloon Use Fails to Help in High-Risk PCI

Jason Kahn

December 11, 2011

News Industry News

FDA Advisory Panel Recommends Expanded Indication for Medtronic Cardiac Resynchronization Therapy with Defibrillator (CRT-D) Devices

December 07, 2011

News Industry News

St. Jude Medical Announces FDA Approval of Industry's First Quadripolar Pacing System

November 28, 2011

News Conference News

No LateTIME Benefit for Cell Therapy After Primary PCI

November 14, 2011

News Industry News

MAQUET Cardiovascular Announces FDA 510(k) Clearance and CE Mark for the Cardiosave Intra-Aortic Balloon Pump

November 09, 2011

News Conference News

PROTECT II: Positive Outcomes Observed with Impella Device

November 08, 2011

Advertisement

Studies Suggest 3-D CT Prior to TAVR Should Be ‘Gold Standard’

Stem Cell Therapy Moderately Improves Cardiac Function After Acute MI

Procedural Complications Not to Blame for Death After PCI

Percutaneous Valve Replacement Stakes Out the Tricuspid

Percutaneous AV Shunt May Do More Harm Than Good in Advanced COPD

La OTC Coronaria Dcha. Predice Mortalidad Tras PCI Principal Dcha

Renal Denervation Bonus: Improving LV Function

El Valor Añadido de la Denervación Renal: Mejora la Función del VI

Mitral Repair Can Augment Heart Function in CABG Patients

La Reparación Mitral Puede Aumentar la Función Cardíaca en Pacientes sometidos a CABG

Novel Strategies Advance Cell Therapy for Cardiomyopathy

Expedited Cell Therapy After STEMI Shows Promise

EVEREST II Registry Looks at MitraClip in High-Risk Patients

Studies Show Valve-in-Valve TAVR Successful for Failed Surgical Bioprostheses

Higher Intra-aortic Balloon Use Fails to Help in High-Risk PCI

FDA Advisory Panel Recommends Expanded Indication for Medtronic Cardiac Resynchronization Therapy with Defibrillator (CRT-D) Devices

St. Jude Medical Announces FDA Approval of Industry's First Quadripolar Pacing System

No LateTIME Benefit for Cell Therapy After Primary PCI

MAQUET Cardiovascular Announces FDA 510(k) Clearance and CE Mark for the Cardiosave Intra-Aortic Balloon Pump

PROTECT II: Positive Outcomes Observed with Impella Device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content